Jinwoo Kim
Research Subjects
Research Interests
Jinwoo Kim has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Aaron Seth Kesselheim
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts USA
1 shared publication - Adrianna McIntyre
Health Policy and Management, Harvard T.H. Chan School of Public Health , Boston, MA 02115
1 shared publication - Benjamin D. Sommers
Brigham & Women’s Hospital, Harvard University, Boston, USA
1 shared publication - Benjamin N. Rome
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
1 shared publication - Jihye Han
Vanderbilt University, Nashville, Tennessee
1 shared publication
Latest Publications
- Open Access
- 29 May 2026
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 4 (6)
Using prescription drug data for timely assessments of state insurance coverage rates: a validation study
Introduction: Timely assessments of insurance coverage are limited by lags and unpredictable data availability. We assessed the performance of real-time prescription data as a proxy for state-level coverage changes. Methods: We analyzed correlations between quarterly state insurance coverage (Medicaid, private insurance, and uninsured) and counts of filled prescriptions per capita by payer (Medicaid, private insurance, and cash-pay/assistance programs) from 2013 to 2024. Regression models measured how predictive prescription counts were of within-state coverage changes. Results: Medicaid prescriptions per capita were strongly correlated with Medicaid coverage (ρ = 0.62). Cash-pay prescriptions per capita were moderately correlated with uninsured rates (ρ = 0.49). Private coverage correlations were weak. Correlations were stronger for adults (ρ = 0.74 for Medicaid, ρ = 0. 52 for uninsured) than children. Among adults, each 10% within-state increase in Medicaid prescriptions was associated with a 7.5% relative increase (95% confidence interval [CI], 5.7%–9.3%) in Medicaid coverage; each 10% increase in cash-pay prescriptions was associated with a 2.5% increase (95% CI, 1.0%–4.1%) in uninsured rates. Conclusions: Real-time prescription drug data are moderately to highly correlated with state-level coverage changes in Medicaid and uninsured rates, particularly for adults. These data may be useful for timely assessments of upcoming policies affecting Medicaid coverage.
- 29 May 2026
- Published by Oxford University Press (OUP) in Health Affairs Scholar
- Vol. 4 (6)
Open AccessUsing prescription drug data for timely assessments of state insurance coverage rates: a validation study
Introduction: Timely assessments of insurance coverage are limited by lags and unpredictable data availability. We assessed the performance of real-time prescription data as a proxy for state-level coverage changes. Methods: We analyzed correlations between quarterly state insurance coverage (Medicaid, private insurance, and uninsured) and counts of filled prescriptions per capita by payer (Medicaid, private insurance, and cash-pay/assistance programs) from 2013 to 2024. Regression models measured how predictive prescription counts were of within-state coverage changes. Results: Medicaid prescriptions per capita were strongly correlated with Medicaid coverage (ρ = 0.62). Cash-pay prescriptions per capita were moderately correlated with uninsured rates (ρ = 0.49). Private coverage correlations were weak. Correlations were stronger for adults (ρ = 0.74 for Medicaid, ρ = 0. 52 for uninsured) than children. Among adults, each 10% within-state increase in Medicaid prescriptions was associated with a 7.5% relative increase (95% confidence interval [CI], 5.7%–9.3%) in Medicaid coverage; each 10% increase in cash-pay prescriptions was associated with a 2.5% increase (95% CI, 1.0%–4.1%) in uninsured rates. Conclusions: Real-time prescription drug data are moderately to highly correlated with state-level coverage changes in Medicaid and uninsured rates, particularly for adults. These data may be useful for timely assessments of upcoming policies affecting Medicaid coverage.